Nonmuscle-invasive bladder cancer, old problems, new insights
Sign Up to like & getrecommendations! Published in 2022 at "Current Opinion in Urology"
DOI: 10.1097/mou.0000000000000997
Abstract: Purpose of review Nonmuscle-invasive bladder cancer (NMIBC) is the most frequent bladder cancer and represents around 75% of bladder cancers. This review will discuss known challenges and recent advances in staging, grading and treatment stratification… read more here.
Keywords: cancer old; bladder; invasive bladder; bladder cancer ... See more keywords
Device-assisted intravesical chemotherapy treatment for nonmuscle invasive bladder cancer: 2022 update
Sign Up to like & getrecommendations! Published in 2022 at "Current Opinion in Urology"
DOI: 10.1097/mou.0000000000001010
Abstract: Purpose of review To critically analyze the oncological outcomes and safety profile of device-assisted intravesical chemotherapy studies reported in 2021. Studies were considered eligible if they included patients with nonmuscle invasive blood cancer (NMIBC), had… read more here.
Keywords: intravesical chemotherapy; device assisted; chemotherapy; assisted intravesical ... See more keywords
Minimal required PDT light dosimetry for nonmuscle invasive bladder cancer
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Biomedical Optics"
DOI: 10.1117/1.jbo.25.6.068001
Abstract: Abstract. Significance: Photodynamic therapy (PDT) could become a treatment option for nonmuscle invasive bladder cancer when the current high morbidity rate associated with red light PDT and variable PDT dose can be overcome through a… read more here.
Keywords: bladder cancer; irradiance; nonmuscle invasive; pdt ... See more keywords
Intravesical Treatment with Electro-Mediated Administration of Mytomicin C as Prophylaxis for Intermediate and High-Risk Nonmuscle-Invasive Bladder Cancer: A Retrospective Multicenter Study
Sign Up to like & getrecommendations! Published in 2019 at "Urologia Internationalis"
DOI: 10.1159/000502663
Abstract: Background: Topical therapy of nonmuscle-invasive bladder cancer (NMIBC) is based on immunotherapy with Bacillus Calmette-Guerin and chemotherapy administered by passive instillation, but an active drug administration achieves a better concentration of the drugs in the… read more here.
Keywords: administration; risk; high risk; treatment ... See more keywords
Alternative Therapies to Bacillus Calmette-Guérin Shortage for Nonmuscle Invasive Bladder Cancer in Brazil and Other Underdeveloped Countries: Management Considerations
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Global Oncology"
DOI: 10.1200/jgo.19.00112
Abstract: Bacillus Calmette-Guérin (BCG) plays a cornerstone role in the management of nonmuscle invasive urothelial carcinoma of the bladder. However, there has been a worldwide intermittent BCG shortage in recent years that may affect the care… read more here.
Keywords: shortage; bladder cancer; bladder; calmette rin ... See more keywords